Investing

Telesis Bio Inc. : TBIO

TBIO

Stock Data

$0.05

$0.00 (0.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutic company, develops drugs to treat diseases caused by protein or gene dysfunction. The company is headquartered in Lexington, Massachusetts.

All TBIO Articles

3 Articles

Lee Jackson | Mar 18, 2021 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Agilent, Carnival, Clorox, Darden, Pinduoduo, QuantumScape, Shell, Williams-Sonoma and More

Thursday's top analyst upgrades and downgrades included Agilent Technologies, Carnival, Clorox, Darden Restaurants, Pinduoduo, QuantumScape, Royal Dutch Shell and Williams-Sonoma.

Jon C. Ogg | Oct 5, 2020 at 9:09 AM EDT

Top Analyst Upgrades and Downgrades: Amex, AT&T, CRISPR, DocuSign, ONEOK, Regeneron, Shopify, Tesla and More

Monday's top analyst upgrades and downgrades included American Express, AT&T, CRISPR Therapeutics, DocuSign, ONEOK, Regeneron Pharmaceuticals, Shopify and Tesla.

Chris Lange | Jun 23, 2020 at 10:07 AM EDT

Why the Sanofi and Translate Bio Vaccine Pact Is Win-Win

Sanofi and Translate Bio are making waves in the fight against the novel coronavirus as the two have agreed to…